Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ace inhibitors attending: chief complaint: sob, chest pressure major surgical or invasive procedure: none history of present illness: f rehab res w/ mult med probs, including cad w/ lbbb, iddm, cri now p/w flu-like sxs (prod cough, rhinorrea) x 1 week, and chest pressure reminiscent of her unstable angina x 1 day which was relieved by 2 sl ntg. of note, 3 other pts at rehab were dx'd w/ influenza, so pt was started on amantadine prophylaxis on . . in ed, noted to be 99.8, hd stable, 95%ra. labs notable for ck of 391, trop 0.82. cxr w/ mild chf and ?rml infiltrate. given levaquin and started on hep/ntg gtts. past medical history: 1)cad 2)cri (bl 1.7) 3)oa 4)gout 5)iddm 6)neuropathy 7)mod mr 8)diastolic chf 9)cva w/ residual l weakness 10)lbbb 11)hyperlipidemia 12)htn 13)mod lvh 14)obesity 15)gerd 16)glaucoma 17)increased cks on statins social history: lives at rehab. enjoys . has a son who is her hcp. family history: nc physical exam: exam notable for 100% on 4l nc speaking in full sentences obese palatal petechiae dry mm diffuse exp wheezes bilat rrr ii?vi murmur 2+ pitting lower ext edema to knees bilat (l sl > r) w/ venostatic changes, guiac negative pertinent results: 08:52pm ck(cpk)-376* tot bili-0.5 08:52pm ck-mb-6 ctropnt-1.20* 08:52pm iron-28* 08:52pm caltibc-238* haptoglob-410* ferritin-453* trf-183* 08:52pm pt-15.3* ptt-78.4* inr(pt)-1.5 01:10pm glucose-122* urea n-46* creat-1.5* sodium-140 potassium-4.4 chloride-98 total co2-32* anion gap-14 01:10pm alt(sgpt)-93* ast(sgot)-86* ck(cpk)-391* alk phos-182* tot bili-0.5 01:10pm ck-mb-7 ctropnt-0.82* 01:10pm iron-20* 01:10pm caltibc-246* ferritin-468* trf-189* 01:10pm urine hours-random 01:10pm urine gr hold-hold 01:10pm wbc-8.0 rbc-3.30* hgb-9.8*# hct-30.1* mcv-91 mch-29.7 mchc-32.6 rdw-14.5 01:10pm neuts-90.9* lymphs-6.5* monos-2.4 eos-0.1 basos-0.1 01:10pm hypochrom-1+ 01:10pm plt count-208 01:10pm pt-14.9* ptt-31.3 inr(pt)-1.4 01:10pm ret aut-1.7 01:10pm urine color-straw appear-clear sp -1.008 01:10pm urine blood-lg nitrite-neg protein-neg glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-5.0 leuk-neg 01:10pm urine rbc-* wbc-0-2 bacteria-occ yeast-none epi-0 admission cxr: chest (pa & lat) 1:01 pm chest (pa & lat) reason: ro pna chf medical condition: year old woman with mi, and flu being treated also for pna reason for this examination: ro pna chf indication: mi, flu, also being treated for pneumonia. shortness of breath. technique: ap and lateral views of the chest were obtained without comparisons. findings: the cardiac silhouette is prominent. the hila are promienntm but not ideally evaluated secondary to technique and patient rotation. mild diffuse prominence of interstitial markings suggest mild chf. there is no evidence of pleural effusion or focal consolidation. there is diffuse osteopenia. impression: likely mild chf. echo: conclusions: the left atrium is moderately dilated. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity size is normal. there is mild regional left ventricular systolic dysfunction. resting regional wall motion abnormalities include inferolateral hypokinesis and inferior hypokinesis/akinesis. right ventricular chamber size and free wall motion are normal. the aortic valve leaflets (3) are mildly thickened. mild (1+) aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. moderate to severe (3+) mitral regurgitation is seen. the tricuspid valve leaflets are mildly thickened. there is no pericardial effusion. compared with the prior study (tape reviewed) of , left ventricular systolic dyfunction is new. sputum: respiratory culture (final ): sparse growth oropharyngeal flora. yeast. moderate growth. staph aureus coag +. moderate growth. oxacillin resistant staphylococci must be reported as also resistant to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. rifampin should not be used alone for therapy. sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | clindamycin----------- =>8 r erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- =>8 r oxacillin------------- =>4 r penicillin------------ =>0.5 r rifampin-------------- <=0.5 s tetracycline---------- <=1 s vancomycin------------ <=1 s brief hospital course: f rehab resident w/ viral bronchitis ?influenza, with possible superimposed pneumonia, anemia of unclear etiology, and elevated troponin nstemi vs demand ischemia. 1)viral bronchitis with evidence of pna on cxr kept on droplet precautions and ruled out for influenza by negative nasal washings. treated bronchitis supportively with nebulizer bronchodilator therapy and inhaled steroids. maintained oxygen saturation in 90s with oxygen by nasal canula. will complete 7 day course of levaquin for presumed cap, as she had a right hilar distribution opacity on cxr. she had a sputum culture which grew out mrsa, likely colonized but conderning for pneumonia. started on vanco on , renally dosed. recieved a midline for vanoc administration for 7 days. her vanco trough will need to be checked before the next dose. 2) nstemi: admission and follow up ekg's only demonstrated old lbbb. no new ischemic changes. she was managed medically with asa, beta blocker and started on (h/o cough with ace-i). enzymes trended down, and echo demonstrated new inferior and infero-lateral wall motion abnormalities. cardiology was involved and recommended medical management and cath at a later time, but the patient and family agreed that she would not want catheterization. 3)diastolic chf: maintained on outpatient regimen and kept a negative fluid balance with lasix regimen. echo continued to show lvh, lae and preserved ef,but also new wall motion abnormalities compared to previous echo. started on this admission. the patient developed a contraction alkolosis after gentle diuresis )4 liters over length of stay) therefore can decrease rate of diuresis with the goal being even - 500 cc negative over 24 hours. 4) anemia: was guiaic negative on rectal exam, and anemia studies were consistent with anemia of chronic disease. this remained stable through hospital course. 5) elevated lfts - unclear etiology but possibly due to passive congestion from chf. trended down through hospital course. 6)cri remained at baseline creatinine. electrolytes and fluid balance were monitored. medications were dosed for her reduced creatinine clearance. 7)gout - stable; allopurinol held during this admission, then restarted on at a renal dosage (qod) 8)dm - continued on insulin per home regimen and covered with sliding scale insulin. diet and finger sticks. continued gabapentin for peripheral neuropathy. 9)h/o cva - residual right sided weakness. continued plavix through hospital course. 10) disposition: to macu at rehab today. medications on admission: combivent allouprunol 100 daily ceftriaxone (stopped ) colace insulin ultram 25 q8 codiene 7.5 mg hs folvent asa 81 plavix 75 aldactone 25 lopressor isordil 40 tid ntg sl prn lasix 40 q8 x3 doses discharge medications: 1. insulin glargine 100 unit/ml solution sig: 58 units subcutaneous at bedtime. 2. insulin regular human 100 unit/ml solution sig: iss injection four times a day: as per ss. 3. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 4. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 5. albuterol sulfate 0.083 % solution sig: one (1) inhalation q2h (every 2 hours) as needed. 6. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po daily (daily). 7. gabapentin 300 mg capsule sig: one (1) capsule po daily (daily). 8. multivitamin capsule sig: one (1) cap po daily (daily). 9. pyridoxine hcl 50 mg tablet sig: one (1) tablet po daily (daily). 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 11. levofloxacin 250 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 7 days. 12. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 13. spironolactone 25 mg tablet sig: one (1) tablet po bid (2 times a day). 14. mirtazapine 15 mg tablet sig: two (2) tablet po hs (at bedtime). 15. codeine-guaifenesin 10-100 mg/5 ml syrup sig: 5-10 mls po q6h (every 6 hours) as needed for cough. 16. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day). 17. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 18. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours). 19. albuterol sulfate 0.083 % solution sig: one (1) inhalation q4h (every 4 hours): may hold if sleeping. 20. heparin sodium (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 21. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily). 22. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po q6h (every 6 hours). 23. allopurinol 100 mg tablet sig: one (1) tablet po every other day (every other day). 24. dibucaine 1 % ointment sig: one (1) appl topical prn (as needed): apply to affected area. 25. fluticasone propionate 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day): rinse mouth afterevery administration. 26. sodium chloride 0.9% flush 3 ml iv daily:prn peripheral iv - inspect site every shift 27. vancomycin hcl 1,000 mg recon soln sig: 1gm intravenous q48 hours for 7 days. 28. furosemide 40 mg tablet sig: two (2) tablet po daily (daily). 29. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed for ha. 30. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). discharge disposition: extended care discharge diagnosis: pneumonia chf nstemi dm htn cri transaminitis discharge condition: fair, on 2 l nc discharge instructions: call your pcp if you have a fever, increased cough, have sob, or chest pain. followup instructions: f/u with pcp 1 - 2 weeks md procedure: transfusion of packed cells diagnoses: pneumonia, organism unspecified subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery mitral valve disorders congestive heart failure, unspecified infection with microorganisms resistant to penicillins percutaneous transluminal coronary angioplasty status ulcer of other part of foot alkalosis unspecified disorder of kidney and ureter late effects of cerebrovascular disease, hemiplegia affecting unspecified side acute bronchitis diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled diastolic heart failure, unspecified mononeuritis of unspecified site nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] swelling, mass, or lump in chest carrier or suspected carrier of other specified bacterial diseases 

Answer: The patient is high likely exposed to